ABSTRACT Background Factors associated with relapse course and disability in myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) remain incompletely understood. Objectives To identify clinical and modifiable factors associated with relapse and disability in MOGAD. Methods In this ambispective multicentre cohort study using data from
Yingtao Wang +23 more
wiley +1 more source
Modeling and Analysis of KSnI<sub>3</sub> Perovskite Solar Cells Yielding Power Conversion Efficiency of 30.21. [PDF]
Kheswa BV +4 more
europepmc +1 more source
A Dynamic Threshold Cancellation Technique for a High-Power Conversion Efficiency CMOS Rectifier. [PDF]
Godinho A +7 more
europepmc +1 more source
Characterizing Cutaneous α‐Synuclein Deposition and Seeding Activity in Parkinson's Disease Subtypes
ABSTRACT Objective Cutaneous phosphorylated α‐synuclein (p‐syn) and α‐synuclein seeding activity are promising biomarkers for Parkinson's disease (PD), but their clinical value remains uncertain due to disease heterogeneity. This study evaluates these two biomarkers in PD patients to inform phenotype‐specific diagnosis and disease severity assessment ...
Yuting Jin +8 more
wiley +1 more source
Dual-Port Six-Band Rectenna with Enhanced Power Conversion Efficiency at Ultra-Low Input Power. [PDF]
Sun S +6 more
europepmc +1 more source
ABSTRACT Objective To determine whether myelin‐sensitive quantitative MRI reveals microstructural abnormalities in normal‐appearing cortex (NACtx) in myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), indicating that conventional MRI underestimates remission residual cortical injury.
Valentina Camera +20 more
wiley +1 more source
TiN/SiO<sub>2</sub> core-shell refractory plasmonic nanostructures unlock unprecedented 26.7% power conversion efficiency in Pb-free perovskite solar cells. [PDF]
Mohsen AA +3 more
europepmc +1 more source
Predicting Power Conversion Efficiency of Organic Photovoltaics: Models and Data Analysis. [PDF]
Eibeck A +8 more
europepmc +1 more source
ABSTRACT Objective To investigate which baseline clinical and imaging characteristics best predict TSPO‐PET‐measurable reduction in glial activation following treatment of multiple sclerosis (MS), to utilize this information for designing more efficient biomarker‐based clinical trials targeting glial activation.
Marlene T. Morch +5 more
wiley +1 more source
20.4% Power conversion efficiency from albedo-collecting organic solar cells under 0.2 albedo. [PDF]
Ren H +6 more
europepmc +1 more source

